Jason Wittes
Stock Analyst at Roth MKM
(3.16)
# 1,065
Out of 4,847 analysts
62
Total ratings
50%
Success rate
0.44%
Average return
Main Sectors:
Stocks Rated by Jason Wittes
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SYK Stryker | Maintains: Buy | $405 → $456 | $381.01 | +19.68% | 11 | May 2, 2025 | |
| ALUR Allurion Technologies | Reiterates: Buy | $16 | $2.85 | +461.40% | 2 | Mar 21, 2025 | |
| MGRM Monogram Technologies | Maintains: Buy | $4 → $5.4 | $2.40 | +125.00% | 2 | Mar 18, 2025 | |
| FBIO Fortress Biotech | Reiterates: Buy | $15 → $16 | $1.84 | +769.57% | 3 | Mar 11, 2025 | |
| OFIX Orthofix Medical | Reiterates: Buy | $22 | $11.08 | +98.65% | 5 | Feb 26, 2025 | |
| IRMD IRADIMED CORPORATION | Reiterates: Buy | $60 → $72 | $59.43 | +21.15% | 3 | Feb 14, 2025 | |
| TLSI TriSalus Life Sciences | Reiterates: Buy | $11 | $5.29 | +107.94% | 2 | Jan 24, 2025 | |
| GMED Globus Medical | Maintains: Buy | $100 → $115 | $59.70 | +92.63% | 4 | Dec 17, 2024 | |
| MNMD Mind Medicine (MindMed) | Maintains: Buy | $36 | $7.69 | +368.14% | 1 | Jul 24, 2024 | |
| DERM Journey Medical | Reinstates: Buy | $11 | $7.24 | +51.93% | 1 | Jun 28, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $10 | $1.31 | +663.36% | 1 | Jun 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reinstates: Buy | $100 | $82.51 | +21.20% | 1 | May 31, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $5 | $2.29 | +118.34% | 4 | Mar 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $9 | $1.57 | +473.25% | 2 | Feb 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $75 | $30.68 | +144.46% | 2 | Oct 20, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $22 | $12.65 | +73.91% | 3 | Oct 20, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $120 | $91.85 | +30.65% | 7 | Oct 20, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $206 | $164.06 | +25.56% | 1 | Sep 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reinstates: Buy | $145 | $217.21 | -33.24% | 1 | Jun 27, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $15 | $10.21 | +46.91% | 2 | Mar 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $200 | $17.04 | +1,073.71% | 3 | Feb 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $26 | $36.41 | -28.59% | 1 | Feb 22, 2017 | |
Stryker
May 2, 2025
Maintains: Buy
Price Target: $405 → $456
Current: $381.01
Upside: +19.68%
Allurion Technologies
Mar 21, 2025
Reiterates: Buy
Price Target: $16
Current: $2.85
Upside: +461.40%
Monogram Technologies
Mar 18, 2025
Maintains: Buy
Price Target: $4 → $5.4
Current: $2.40
Upside: +125.00%
Fortress Biotech
Mar 11, 2025
Reiterates: Buy
Price Target: $15 → $16
Current: $1.84
Upside: +769.57%
Orthofix Medical
Feb 26, 2025
Reiterates: Buy
Price Target: $22
Current: $11.08
Upside: +98.65%
IRADIMED CORPORATION
Feb 14, 2025
Reiterates: Buy
Price Target: $60 → $72
Current: $59.43
Upside: +21.15%
TriSalus Life Sciences
Jan 24, 2025
Reiterates: Buy
Price Target: $11
Current: $5.29
Upside: +107.94%
Globus Medical
Dec 17, 2024
Maintains: Buy
Price Target: $100 → $115
Current: $59.70
Upside: +92.63%
Mind Medicine (MindMed)
Jul 24, 2024
Maintains: Buy
Price Target: $36
Current: $7.69
Upside: +368.14%
Journey Medical
Jun 28, 2024
Reinstates: Buy
Price Target: $11
Current: $7.24
Upside: +51.93%
Jun 26, 2024
Initiates: Buy
Price Target: $10
Current: $1.31
Upside: +663.36%
May 31, 2024
Reinstates: Buy
Price Target: $100
Current: $82.51
Upside: +21.20%
Mar 5, 2024
Reiterates: Buy
Price Target: $5
Current: $2.29
Upside: +118.34%
Feb 13, 2024
Initiates: Buy
Price Target: $9
Current: $1.57
Upside: +473.25%
Oct 20, 2023
Initiates: Buy
Price Target: $75
Current: $30.68
Upside: +144.46%
Oct 20, 2023
Initiates: Buy
Price Target: $22
Current: $12.65
Upside: +73.91%
Oct 20, 2023
Initiates: Neutral
Price Target: $120
Current: $91.85
Upside: +30.65%
Sep 14, 2022
Initiates: Buy
Price Target: $206
Current: $164.06
Upside: +25.56%
Jun 27, 2022
Reinstates: Buy
Price Target: $145
Current: $217.21
Upside: -33.24%
Mar 3, 2022
Initiates: Buy
Price Target: $15
Current: $10.21
Upside: +46.91%
Feb 8, 2022
Initiates: Buy
Price Target: $200
Current: $17.04
Upside: +1,073.71%
Feb 22, 2017
Initiates: Buy
Price Target: $26
Current: $36.41
Upside: -28.59%